Assessing the Importance of Variation in Diagnostic Coding Among the Three Countries in the UK Biobank. [PDF]
Clifton L +6 more
europepmc +1 more source
Development and Validation of the AI-HeartAge Model in Framingham and UK Biobank. [PDF]
Korzinski TJ +9 more
europepmc +1 more source
Plasma EDA2R and Risk of Cardiovascular Diseases and All-Cause Mortality: Analysis of the UK Biobank Cohort. [PDF]
Ruan Z +6 more
europepmc +1 more source
Clonal haematopoiesis and risk of incident rheumatoid arthritis: results from the UK Biobank. [PDF]
Cui J +9 more
europepmc +1 more source
Serum lipid profiles and risk of depression: a UK Biobank prospective cohort study. [PDF]
Du M, Li C.
europepmc +1 more source
Response to 'Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK Biobank'. [PDF]
Law PJ, Went M, Houlston RS.
europepmc +1 more source
Lipoprotein(a), Insulin Resistance, and Cardiovascular Disease in the UK Biobank. [PDF]
Kazibwe R +12 more
europepmc +1 more source
Intensity matters: vigorous activity is associated with lower pressure-independent arterial stiffness in the UK Biobank. [PDF]
Norling AM, Dufour AB, Lipsitz LA.
europepmc +1 more source
Plasma Metabolomic Associations with Incident Rhegmatogenous Retinal Detachment in UK Biobank. [PDF]
Gao Y +10 more
europepmc +1 more source

